CAR-M therapy LIB820 may deplete disease-driving B-cells in MS and other autoimmune diseases without severe side effects, new ...

Columnist Lindsay Kelly discusses the importance of recognizing and addressing caregiver burnout before reaching your ...

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

MRI and disability scores better identify cognitive decline in stable RRMS patients than blood biomarkers, according to a new ...

Miniature brain models (organoids) help evaluate treatments for myelin damage in multiple sclerosis. These human-derived ...

A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...

This year's Bike MS event in Texas, the largest such U.S. fundraiser, brought in $9.2 million for research, advocacy, and ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

Decode Health and Circular Genomics will use AI to identify patterns in circular RNA in blood that may help diagnose and ...

Researchers found the nerve damage biomarker NfL in menstrual fluid, meaning tampon-collected samples could help monitor ...